Skip to main content

Table 5 Imaging features and pathological characteristics of patients with GGOs

From: “Low-age, low-frequency” lung cancer screening strategies maybe adaptable to the situation in China

Variables

GGO in Group A

n = 601

N(%)or Median

GGO in Group B

n = 1320

N(%)or Median

P value

NO. OF LESIONS, DETECTED PER PATIENT

  

P < 0.05

 1

462 (76.9)

1165 (88.3)

 

 2

108 (18)

113 (8.6)

 3

25 (4.2)

30 (2.3)

 ≥ 4

6 (1.0)

12 (0.9)

RADIOLOGICAL SIZE OF SOLID COMPONENT (MM)

  

P < 0.05

 Median

9

7

 

RADIOLOGICAL TUMOR SIZE (MM)

  

P < 0.05

 Median

11

12

 

CTR

  

P < 0.05

 0

463 (77.0)

1105 (83.7)

 

 > 0, < 0.5

63 (10.5)

110 (8.3)

 ≥ 0.5, < 1

75 (12.5)

105 (8)

PATHOLOGICAL STAGE

  

P < 0.05

 AAH

16 (2.6)

58 (4.4)

 

 AIS

139 (23.2)

210 (15.9)

 MIA

121 (20.1)

432 (32.7)

 IAC

240 (40.1)

540 (41.0)

 Squamous cell carcinoma

3 (0.5)

3 (0.2)

 Small cell lung cancer

0 (0)

3 (0.2)

 Metastatic cancer

2 (0.3)

0 (0)

 Other malignant tumors

4 (0.6)

1 (0.1)

 Benign

76 (12.6)

73 (5.5)

TNM CLASSIFICATION

  

P < 0.05

 0

150 (25)

246 (18.6)

 

 IA1

217 (36.1)

611 (46.3)

 IA2

146 (24.3)

332 (25.1)

 IA3

36 (6)

71 (5.4)

 IB

37 (6.2)

46 (3.5)

 IIA

0 (0)

1 (0.1)

 IIB

5 (0.8)

9 (0.7)

 IIIA

10 (1.6)

4 (0.3)

  1. NO. number, AAH atypical adenomatous hyperplasia, AIS adenocarcinoma in situ, MIA microinvasive adenocarcinoma, IAC invasive adenocarcinoma